Kari Pekka Pitkänen
Director/Board Member bei Scellex Oy
Vermögen: 5 Mio $ am 31.03.2024
Profil
Kari Pekka Pitkänen founded Aiforia Technologies Oyj in 2013, where he worked as Director-Business Development from 2021 to 2023.
Mr. Pitkänen also currently works at Scellex Oy, as Director from 2019 and Genna Health Oy, as Director from 2020.
Mr. Pitkänen also formerly worked at Finnzymes Oy, as Marketing Director.
Mr. Pitkänen received his graduate degree from Aalto University School of Science & Technology.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
31.08.2023 | 1 181 000 ( 4,55% ) | 5 Mio $ | 31.03.2024 |
Aktive Positionen von Kari Pekka Pitkänen
Unternehmen | Position | Beginn |
---|---|---|
Scellex Oy | Director/Board Member | 01.01.2019 |
Genna Health Oy | Director/Board Member | 01.01.2020 |
Ehemalige bekannte Positionen von Kari Pekka Pitkänen
Unternehmen | Position | Ende |
---|---|---|
AIFORIA TECHNOLOGIES OYJ | Founder | 01.01.2023 |
Finnzymes Oy
Finnzymes Oy Pharmaceuticals: MajorHealth Technology The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise. | Sales & Marketing | - |
Ausbildung von Kari Pekka Pitkänen
Aalto University School of Science & Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AIFORIA TECHNOLOGIES OYJ | Technology Services |
Private Unternehmen | 3 |
---|---|
Finnzymes Oy
Finnzymes Oy Pharmaceuticals: MajorHealth Technology The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise. | Health Technology |
Scellex Oy | |
Genna Health Oy |